Prednisolone (Rheumatology)
Brand names: Deltacortril, Precortisyl Forte
Prednisolone is an oral glucocorticoid widely used in rheumatology to control inflammation in conditions such as polymyalgia rheumatica, giant cell arteritis, inflammatory arthritis flares and connective tissue diseases.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is a synthetic corticosteroid that binds the glucocorticoid receptor to suppress pro-inflammatory gene transcription and immune cell activity, producing broad anti-inflammatory and immunosuppressive effects.
Prescribing in practice
- Never stop long-term or higher-dose therapy abruptly because of the risk of adrenal insufficiency — taper gradually and issue a steroid emergency card with advice to increase the dose during intercurrent illness.
- Prolonged use causes osteoporosis, so assess fracture risk and offer bone protection in line with NICE guidance, alongside vigilance for hyperglycaemia, hypertension and infection.
- It increases susceptibility to infection and can mask its signs, and live vaccines should generally be avoided at immunosuppressive doses.
Monitoring
Monitor blood pressure, weight, blood glucose and bone health on longer courses, and review for infection, mood change and gastrointestinal symptoms at follow-up.
Counselling the patient
- Do not stop suddenly and carry your steroid card at all times.
- Take it in the morning, ideally with food.
- Seek advice promptly if you feel unwell or develop an infection.
Evidence & guidelines
Glucocorticoids are long-established and trial-supported in rheumatology, with giant cell arteritis being a clear example where prompt prednisolone prevents visual loss.
Reference: BSR PMR/GCA Guidelines; NOGG osteoporosis guidelines; NICE CG169; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AF · Anticoagulation
- SIRS Criteria and Sepsis Definition · Sepsis
- Steroid Dose Equivalence · Medications
- Neutrophil-to-Lymphocyte Ratio (NLR) · Inflammatory Markers
- Maddrey Discriminant Function (Alcoholic Hepatitis) · Alcoholic Liver Disease
- Lille Model (Steroid Response in Alcoholic Hepatitis) · Alcoholic Liver Disease
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022